Research Commercialisation
Asia Leaders
Feng Zhang Won $34.5 Million for Paediatric Epilepsy Editing. A Shared Platform Must Defeat Rare-Disease Economics
Feng Zhang’s ARPA-H-backed PERC consortium targets two severe childhood epilepsies first. Its real value will be whether one platform can lower the cost of treating many ultra-rare diseases.
Asia Leaders
Demis Hassabis Moved DeepMind Deeper Into the Laboratory. Scientific AI Needs a Verification Business Model
Demis Hassabis is building a wider scientific-AI stack around AlphaGenome and Co-Scientist. The opportunity is large, but laboratories need reproducible gains rather than fluent novelty.
Asia Leaders
Chuan He Connected Diet, RNA Marks and Early Immunity. Product Builders Must Separate Signal From Platform
Chuan He’s latest research brings RNA regulation into early-life immunity, learning and development. The opportunity is broad, but commercial claims must stay behind causal evidence.
Asia Leaders
Anima Anandkumar Put Neural Operators on Firmer Ground. Scientific AI Must Earn Its Compute
Anima Anandkumar’s neural-operator research targets reusable scientific models rather than one-off predictions. Adoption will depend on verification, compute economics and domain trust.
Asia Leaders
Shimon Sakaguchi Extended Treg Science Into Cancer and Heart Failure. Translation Must Now Prove Its Range
Shimon Sakaguchi’s 2026 research links Treg biology to checkpoint response and heart-failure fibrosis. Platform value will depend on reproducibility, manufacturing and patient selection.
Asia Leaders
Omar M. Yaghi Pulled Carbon From Open Air With COFs. Deployment Must Beat the Energy Bill
Omar M. Yaghi’s 2026 work pairs direct-air carbon capture with ambitious framework design. Commercialisation depends on energy use, material lifetime and repeatable manufacturing.
Asia Leaders
Susumu Kitagawa Made Porous Crystals More Selective. Industrial Separation Will Test Their Economics
Susumu Kitagawa’s 2026 MOF research advances selective carbon-dioxide and ammonia capture. Commercial value will turn on lifetime cost, process integration and industrial-scale production.